4//SEC Filing
Gerber Hans-Peter 4
Accession 0001992979-25-000003
CIK 0001382101other
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 5:01 PM ET
Size
9.0 KB
Accession
0001992979-25-000003
Insider Transaction Report
Form 4
Gerber Hans-Peter
CHIEF SCIENTIFIC OFFICER
Transactions
- Exercise/Conversion
Restricted Stock Units (RSUs)
2025-09-18−37,500→ 75,000 totalExp: 2027-09-18→ Common Stock (37,500 underlying) - Exercise/Conversion
Common Stock
2025-09-18+37,500→ 68,249 total - Tax Payment
Common Stock
2025-09-18$0.90/sh−13,417$12,075→ 54,832 total
Footnotes (3)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
- [F3]The RSU award vests annually as to 1/4th of the total award beginning on September 18, 2024, subject to the reporting person's continued service to the Issuer on each vesting date.
Documents
Issuer
SUTRO BIOPHARMA, INC.
CIK 0001382101
Entity typeother
Related Parties
1- filerCIK 0001992979
Filing Metadata
- Form type
- 4
- Filed
- Sep 21, 8:00 PM ET
- Accepted
- Sep 22, 5:01 PM ET
- Size
- 9.0 KB